Username
Oncology
Early Phase / Multiple Disease Site
Hematologic Malignancies
Early Phase Team
Lymphoma
NHL
WM
menu
Search
Should appear
Must not appear
Categories
Search
2 or more prior lines
Protocols
show categories
Search
NURIX-NX-5948-301
Phase I
OPEN TO ACCRUAL
A Phase 1, Dose Escalation, and Cohort Expansion Study Evaluating NX-5948, a Bruton's Tyrosine Kinase (BTK) Degrader, in Adults with Relapsed/Refractory B-cell Malignancies
Search